Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INHALEd Unfractionated HEParin for the Treatment of Hospitalised Patients With COVID-19 Meta-trial

NCT04635241 is registered in ClinicalTrials.gov with Australian National University as lead sponsor.

NCT NCT04635241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04635241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INHALEd Unfractionated HEParin for the Treatment of Hospitalised Patients With COVID-19 Meta-trial
Lead sponsor
Australian National University
Phase
Phase 2/3
Overall status
Completed
Start date
June 1, 2020
Completion date
January 18, 2025
Enrollment
485 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid19